- Home
- MGRM vs CRVO Comparison
MGRM vs CRVO Comparison
Compare MGRM & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRM
- CRVO
- Stock Information
- Founded
- MGRM 2016
- CRVO 2001
- Country
- MGRM United States
- CRVO United States
- Employees
- MGRM N/A
- CRVO N/A
- Industry
- MGRM Medical/Dental Instruments
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- MGRM Health Care
- CRVO Health Care
- Exchange
- MGRM Nasdaq
- CRVO Nasdaq
- Market Cap
- MGRM 89.6M
- CRVO 98.3M
- IPO Year
- MGRM N/A
- CRVO N/A
- Fundamental
- Price
- MGRM $2.57
- CRVO $2.11
- Analyst Decision
- MGRM Strong Buy
- CRVO Buy
- Analyst Count
- MGRM 1
- CRVO 8
- Target Price
- MGRM $4.00
- CRVO $38.75
- AVG Volume (30 Days)
- MGRM 63.8K
- CRVO 303.4K
- Earning Date
- MGRM 03-14-2025
- CRVO 11-12-2024
- Dividend Yield
- MGRM N/A
- CRVO N/A
- EPS Growth
- MGRM N/A
- CRVO N/A
- EPS
- MGRM N/A
- CRVO N/A
- Revenue
- MGRM $364,999.00
- CRVO $10,066,550.00
- Revenue This Year
- MGRM N/A
- CRVO $34.17
- Revenue Next Year
- MGRM N/A
- CRVO N/A
- P/E Ratio
- MGRM N/A
- CRVO N/A
- Revenue Growth
- MGRM N/A
- CRVO 116.29
- 52 Week Low
- MGRM $1.53
- CRVO $1.80
- 52 Week High
- MGRM $4.90
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- MGRM 54.65
- CRVO 28.68
- Support Level
- MGRM $2.35
- CRVO $2.03
- Resistance Level
- MGRM $2.80
- CRVO $2.17
- Average True Range (ATR)
- MGRM 0.20
- CRVO 0.16
- MACD
- MGRM -0.01
- CRVO 0.30
- Stochastic Oscillator
- MGRM 54.00
- CRVO 23.08
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.